Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.34 +0.19 (+4.58%)
At close: Nov 11, 2026 · 4:00 PM EST

Aclaris Therapeutics (ACRS) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Aclaris Therapeutics (ACRS) reported Return on Capital Employed [ROCE] of -53.62% for Q2 2026, up 34.30 percentage points from -87.92% a year earlier but down 0.75 percentage points from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Aclaris Therapeutics posted Return on Capital Employed [ROCE] of -47.22%, up 32.85 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +25.86 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -80.07% in FY2024 (-30.15 pp), -49.91% in FY2023 (-11.01 pp), -38.90% in FY2022 (+26.08 pp) and -64.99% in FY2021 (+8.09 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -97.83% in Q3 2025 and a high of -30.28% in Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of -5.79 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2021 (a gain of 52.45 percentage points); the low point was Q3 2025 (a drop of 67.55 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -52.87% (Q1 2026), -54.81% (Q4 2025) and -97.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Aclaris Therapeutics 625.92 Mn 223.91 Mn 1.29 Mn -52.11%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -52.11%
Jun 30, 2026 -53.62%
Mar 31, 2026 -52.87%
Dec 31, 2025 -54.81%
Sep 30, 2025 -97.83%
Jun 30, 2025 -87.92%
Mar 31, 2025 -75.17%
Dec 31, 2024 -83.60%
Sep 30, 2024 -30.28%
Jun 30, 2024 -44.38%
Mar 31, 2024 -52.14%
Dec 31, 2023 -55.03%
Sep 30, 2023 -61.29%
Jun 30, 2023 -53.22%
Mar 31, 2023 -45.05%
Dec 31, 2022 -37.57%
Sep 30, 2022 -33.07%
Jun 30, 2022 -35.20%
Mar 31, 2022 -36.06%
Dec 31, 2021 -38.27%
API Access

Aclaris Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ACRS&period=max&api_key=YOUR_API_KEY